MYO10与恶性肿瘤的研究进展

doi:10.11904/j.issn.1002-3070.2021.03.015

Abstract

Abstract: Myosin X(MYO10)is a molecular motor based on actin,which can induce the formation of filopodia and promote cell migration in vitro and in vivo.In recent years,many studies have shown that the abnormal expression of MYO10 in the formation of invasive pseudopodia is closely related to the invasion and metastasis of malignant tumors.This article reviews the biological function of MYO10 and its research progress in the occurrence and development of malignant tumors.

Key words: Myosin X, Invasive pseudopodia, Malignant tumors, Metastasis

CLC Number:

R730.7

GUO Haonan, QIN Tao. Research progress of MYO10 and malignant tumors[J]. Journal of Practical Oncology, 2021, 35(3): 273-276.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2021.03.015

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2021/V35/I3/273

References

1 Eddy RJ,Weidmann MD,Sharma VP,et al.Tumor cell invadopodia:invasive protrusions that orchestrate metastasis[J].Trends Cell Biol,2017,27(8):595-607.
2 黄蕾,滕春莹,雷鹏,等.伪足,有氧糖酵解与肿瘤细胞迁移的研究进展[J].癌变·畸变·突变,2020,32(1):72-75.
3 Sandquist JC,Larson ME,Hine KJ.Myosin-10 independently influences mitotic spindle structure and mitotic progression[J].Cytoskeleton,2016,73(7):351-364.
4 Solc CK,Derfler BH,Duyk GM,et al.Molecular cloning of myosins from bullfrog saccular macula:a candidate for the hair cell adaptation motor[J].Auditory Neurosci,1994,1:61-75.
5 Courson DS,Cheney RE.Myosin-X and disease[J].Exp Cell Res,2015,334(1):10-15.
6 Pi X,Ren R,Kelley R,et al.Sequential roles for myosin-X in BMP6-dependent filopodial extension,migration,and activation of BMP receptors[J].J Cell Biol,2007,179(7):1569-1582.
7 Bachg AC,Horsthemke M,Skryabin BV,et al.Phenotypic analysis of Myo10 knockout(Myo10(tm2/tm2))mice lacking full-length(motorized)but not brain-specific headless myosin X[J].Sci Rep,2019,9(1):597.
8 Zhang H,Berg JS,Li Z,et al.Myosin-X provides a motor-based link between integrins and the cytoskeleton[J].Nat Cell Biol,2004,6(6):523-531.
9 Lai M,Guo Y,Ma J,et al.Myosin X regulates neuronal radial migration through interacting with N-cadherin[J].Front Cell Neurosci,2015,9:326.
10 Zhang J,Li Y,Qi J,et al.Circ-calm4 serves as an miR-337-3p sponge to regulate Myo10(Myosin 10)and promote pulmonary artery smooth muscle proliferation[J].Hypertension,2020,75(3):668-679.
11 Tasca A,Astleford K,Lederman A,et al.Regulation of osteoclast differentiation by myosin X[J].Sci Rep,2017,7(1):7603.
12 Mao Y,Yang D,He J,et al.Epidemiology of lung cancer[J].Surg Oncol Clin N Am,2016,25(3):439-445.
13 Sun Y,Ai X,Shen S,et al.NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10[J].Oncotarget,2015,6(10):8244-8254.
14 Dvornikov D,Schneider MA,Ohse S,et al.Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response[J].Sci Rep,2018,8(1):9517.
15 Summerbell ER,Mouw JK.Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning[J].Sci Adv,2020,6(30):6197.
16 Schito L,Rey S.Hypoxic pathobiology of breast cancer metastasis[J].Biochim Biophys Acta Rev Cancer,2017,1868(1):239-245.
17 Cao R,Chen J,Zhang X,et al.Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis[J].Br J Cancer,2014,111(3):539-550.
18 Arjonen A,Kaukonen R,Mattila E,et al.Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis[J].J Clin Invest,2014,124(3):1069-1082.
19 Chen CP,Sun ZL,Lu X,et al.MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer[J].Oncol Rep,2016,35(2):709-716.
20 刘恒昌,魏然,李春香,等.NOX4在结肠癌组织中的表达及与预后的关系[J].实用肿瘤学杂志,2020,34(5):391-397.
21 Zhu XJ,Wang CZ,Dai PG,et al.Myosin X regulates netrin receptors and functions in axonal path-finding[J].Nat Cell Biol,2007,9(2):184-192.
22 Liu Y,Peng Y,Dai PG,et al.Differential regulation of myosin X movements by its cargos,DCC and neogenin[J].J Cell Sci,2012,125(3):751-762.
23 欧海斌,隋铭,邵晶,等.非传统型肌球蛋白Myo10对结肠癌细胞SW620生长的影响及其机制[J].武汉大学学报(医学版),2019,40(4):552-557.
24 Zhang X,Fang Q,Ma Y,et al.Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer[J].Am J Cancer Res,2019,9(9):1995-2006.
25 Mallepalli S,Gupta MK,Vadde R.Neuroblastoma:an updated review on biology and treatment[J].Curr Drug Metab,2019,20(13):1014-1022.
26 Wang X,Li J,Xu X,et al.miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10[J].Biomed Pharmacother,2018,103:1312-1318.
27 Wang SY,Wang X,Zhang CY.LncRNA SNHG7 enhances chemoresistance in neuroblastoma through cisplatin-induced autophagy by regulating miR-329-3p/MYO10 axis[J].Eur Rev Med Pharmacol Sci,2020,24(7):3805-3817.
28 Lugović-Mihić L,Ćesić D,Vuković P,et al.Melanoma development:current knowledge on melanoma pathogenesis[J].Acta Dermatovenerol Croat,2019,27(3):163-168.
29 Tokuo H,Bhawan J,Coluccio LM.Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis[J].Sci Rep,2018,8(1):10449.
30 Makowska KA,Hughes RE,White KJ,et al.Specific myosins control actin organization,cell morphology,and migration in prostate cancer cells[J].Cell Rep,2015,13(10):2118-2125.
31 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
32 He JH,Chen JG,Zhang B,et al.Elevated MYO10 predicts poor prognosis and its deletion hampers proliferation and migration potentials of cells through rewiring PI3K/Akt signaling in cervical cancer[J].Technol Cancer Res Treat,2020,19(19):153303382093677.
33 Umeki N,Jung HS,Sakai T,et al.Phospholipid-dependent regulation of the motor activity of myosin X[J].Nat Struct Mol Biol,2011,18(7):783-788.
34 Uhl J,Gujarathi S,Waheed AA,et al.Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes[J].J Cell Commun Signal,2019,13(2):209-224.

[1]	YANG Siqi,SONG Qibin,LI Qingqing,YAO Yi. Research progress of targeted inhibition of FGFRs signal in the treatment of malignant tumors [J]. Journal of Practical Oncology, 2021, 35(1): 73-77.
[2]	NIU Ming, YU Ge. Gankyrin promotes tumor proliferation,metastasis and cancer stem cell characteristic in breast cancer [J]. Journal of Practical Oncology, 2020, 34(6): 518-523.
[3]	LI Yunxue, WANG Gang, SUN Bei, ZUO Qian, WU Linfeng. Treatment attitude and the status of diagnosis and treatment in neck lymph nodes of papillary thyroid cancer [J]. Journal of Practical Oncology, 2020, 34(6): 530-534.
[4]	SONG Jiayu, FENG Yue, WANG Zhao, ZHANG Yunyan. The latest research progress of the correlation between exosomes and gynecological malignant tumor [J]. Journal of Practical Oncology, 2020, 34(6): 571-575.
[5]	YUAN Yao, ZHOU Xianli. Research progress on the correlation between ultrasound features and axillary lymph node metastasis in breast cancer [J]. Journal of Practical Oncology, 2020, 34(6): 576-580.
[6]	DONG Manku, JIANG Fuquan, LIN Haiguan, SUN Xiaomin, LIU Jingxin, HU Gang, YANG Jianwu. LncRNA BLACAT1 targeting LEMD1 promotes the proliferation and metastasis of colorectal cancer cells [J]. Journal of Practical Oncology, 2020, 34(5): 418-424.
[7]	SHI Linna,SUI Hong. Research status for evaluation methods of lymph node metastasis in the early gastric cancer [J]. Journal of Practical Oncology, 2020, 34(3): 286-290.
[8]	ZHANG Jinglan, LIU Ruibao. Progress in local interventional therapy for colorectal cancer with liver metastasis [J]. Journal of Practical Oncology, 2020, 34(1): 79-82.
[9]	SHEN Yizhe, GUO Baoliang. Progress in local treatment of newly diagnosed stage IV breast cancer [J]. Journal of Practical Oncology, 2019, 33(6): 575-578.
[10]	XU Ting, YAN Feifei, ZHANG Chunhui, ZHANG Yanqiao. Analysis of clinical pathology and prognosis in patients with gastric cancer & bone metastasis [J]. Journal of Practical Oncology, 2019, 33(5): 436-441.
[11]	ZHANG Ning, LAN Xueling. Predictive effect of ferritin on cervical lymph node metastasis in head and neck cancer [J]. Journal of Practical Oncology, 2019, 33(5): 442-446.
[12]	CHEN Hongbo, YU Zengrong, DING Xiaofan, XIAO Lin. Progress of correlation between bone marrow dose-volume parameters and acute hematologic toxicity in pelvic malignant tumor [J]. Journal of Practical Oncology, 2019, 33(4): 361-366.
[13]	MENG Hai,DU Guanxiang,ZHU Liling,TANG Qiyun. The expression of WEE1 in gastric cancer and its influence on prognosis of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 239-243.
[14]	LI Jiaqi,LUAN Jinwei,ZHANG Yu,LI Xianglan. Analysis of clinicopathological features,recurrence and metastasis in 763 triple-negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 244-249.
[15]	YU Fang, ZHAO Pei. The role and mechanism of TRAP1 in the development of esophageal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 515-519.

Research progress of MYO10 and malignant tumors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments